Home 主打产品 植物提取物 天然提取物 产品目录 产品解决方案 展会 联系我们
新橙皮甙二氢查尔酮Neohesperidin dihydrochalcone
新橙皮苷Neohesperidin 95%
柚皮苷Naringin 95%-98%
枳实黄酮citrus bioflavonoids
辛弗林synephrine
橙皮苷Hesperidin
柚皮素Naringenin
地奥司明Diosmin
甲基橙皮甙methyl hesperidin
柚皮苷二氢查耳酮naringin dihydrochalcone
莽草酸Shikimic acid
山竹提取物Mangosteen extract
齐墩果酸oleanolic acid
洗树碱Camptothecin
青蒿素Artemisinin
獐芽菜苦甙Swertimarin
黄芩素baicalein
黄芩苷Baicalin
盐酸小檗碱Berberine hydrochloride
萝卜硫素Sulforaphane
萝卜硫甙Glucoraphanin
根皮素Phloretin
根皮甙Phlorizin
元宝枫提取物神经酸nervonic acid
刺五加提取物Siberian Ginseng Extract

枳实黄酮citrus bioflavonoids 

枳实黄酮

品名:枳实黄酮

植物来源:Citrus aurantium Synonyn
颜色深棕色粉末
主要成分Neohesperidin and naringin
提取部位
检测方式:HPLC/UV

枳实黄酮,由枳实中提取而得。具有抗氧化、抗菌与抗病毒、 与抗肿瘤、抗炎,调节免疫活性、治疗心血管疾病、解毒护肝、影响内分泌和代谢等药理作用。

 

【成分】

枳实中黄酮类化合物主要有橙皮有、柚皮苷、新橙皮苷、以及酸橙素、苦橙苷、枸桔苷、苦橙丁等。

【理化性质】

(1)黄酮类化合物多为结晶性固体,少数为无定形粉末。黄酮类化合物的分子结构中,大多带有酚轻基,因此具有酚类化合物的通性。

(2)另外,分子中还常带有毗酮环或碳基,构成了生色团的基本结构,根据羟基的数目,结合的位置与交叉共扼体系,构成了黄酮类化合物的呈色。黄酮、黄酮醇及其苷类多为灰黄至黄色双氢黄酮、双氢黄酮醇无交叉共轭体系一般不显色;异黄酮类因共扼体系较短,显微黄色花色素所显颜色与有关,不同的条件下会呈现出红、紫、蓝等颜色。

(3)对于黄酮苷元,分子内含有不对称碳原子的双氢黄酮、双氢黄酮醇、黄烷醇、双氢异黄酮及其衍生物,具有旋光性,其余苷元则无旋光性。黄酮苷类因结构中含有糖的分子,均含有旋光性,且多为左旋。

(4)黄酮类化合物的溶解度因结构及存在状态苷或苷元,单糖苷,双糖苷或三糖苷不同而有很大差异。一般游离苷元难溶于水,易溶于甲醇、乙醇、氯仿、乙酸乙酯等有机溶剂而黄酮苷一般易溶于水、甲醇、乙醇等极性溶剂,难溶或不溶于苯、氯仿等有机溶剂。

(5)黄酮类化合物多具有强的荧光,在紫外灯照射下呈亮黄、黄绿、亮蓝、暗棕等颜色。

(6)黄酮类化合物对盐酸镁粉或汞齐呈鲜红、紫色或黄色反应。结构中带有3一OH,5一OH或邻位羟基者,均能与金属盐类试剂如铝盐、镁盐、腮盐、铁盐等形成颜色较深的络合物。

产品详询:13657416805

参考文献:

 

  1. 1.

    Abraham P, Wilfred G, Cathrine: Oxidative damage to the lipids and proteins pf the lungs, testis and kidney of rats during carbon tetrachloride intoxication. Clin Chim Acta. 1999, 289: 177-179. 10.1016/S0009-8981(99)00140-0.

  2. 2.

    Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, Slomka M, Madro A, Celinski K, Wielosz M: Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg. 2003, 10: 309-315. 10.1007/s00534-002-0824-5.

  3. 3.

    Guven A, Guven A, Gulmez M: The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetrachloride-induced mice tissue. J Vet Med B Infect Dis Vet Public Health. 2003, 50: 412-416.

  4. 4.

    Ahmad FF, Cowan DL, Sun AY: Detection of free radical formation in various tissues after acute carbon tetrachloride administration in gerbil. Life Sci. 1987, 41: 2469-2475. 10.1016/0024-3205(87)90673-4.

  5. 5.

    Ohta Y, Nishida K, Sasaki E, Kongo M, Ishiguro I: Attenuation of disrupted hepatic active oxygen metabolism with the recovery of acute liver injury in rats intoxicated with carbon tetrachloride. Res Commun Mol Pathol Pharmacol. 1997, 95: 191-207.

  6. 6.

    Ozturk F, Ucar M, Ozturk IC, Vardi N, Batcioglu K: Carbon tetrachloride-induced nephrotoxicity and protective effect of betaine in Sprague-Dawley rats. Urology. 2003, 62: 353-356.

  7. 7.

    Perez AJ, Courel M, Sobrado J, Gonzalez L: Acute renal failure after topical application of carbon tetrachloride. Lancet. 1987, 1: 515-516.

  8. 8.

    Churchill DN, Finn A, Gault M: Association between hydrocharbon exposure and glomerulonephritis.An araisal of the evidence. Nephron. 1983, 33: 169-172.

  9. 9.

    Ruprah H, Mant TGK, Flanagan RJ: Acute carbon tetrachloride poisoning in19 pateints: implications for diagnosis and treatment. Lancet. 1985, i: 1027-1029. 10.1016/S0140-6736(85)91624-1.

  10. 10.

    Yoshikawa T, Furukawa Y, Murakami M, Takemura S, Kondo M: Effect of viatmin E on D-Galactosamine-induced or carbon tetrachloride-induced hepatotoxicity. Digestion. 1982, 25: 222-229.

  11. 11.

    Ko KM, Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC: Effect of a lignan-enriched fructus schisandrae extract on hepatic glutathione status in rats: protection against carbon tetrachloride toxicity. Planta Med. 1995, 61: 134-137. 

  12. 12.

    Garg A, Garg S, Zaneveld LJ, Singla AK: Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res. 2001, 15: 655-669. 10.1002/ptr.1074.

  13. 13.

    Jovanovic SV, Steenken S, Tosic M, Marjanovic B, Simic MG: Flavonoids as anti-oxidants. J Am Chem Soc. 1994, 116: 4846-4851.

  14. 14.

    Fraga CG, Martino VS, Ferraro GE, Coussio JD, Boveris A: Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Pharmacol. 1987, 36: 717-720. 10.1016/0006-2952(87)90724-6. 

  15. 15.

    Miller NJ, Rice-Evans CA: The relative contribution of ascorbic acid and phenolic antioxidants to the total antioxidant activity of orange and apple fruit juices and balckcurrant drink. Food Chem. 1997, 60: 331-337. 10.1016/S0308-8146(96)00339-1.

  16. 16.

    Suarez , Herrera MD, Marhuenda E: In vitro scavenger and antioxidant properites of hesperidin and neohesperidin dihydrochalcone. Phytomedicine. 1998, 5: 469-473.

  17. 17.

    Recknagel RO: Carbon tetrachloride hepatotoxicity: Status quo and future prospects. TIPS. 1983, March: 129-131.

  18. 18.

    Recknagel RO, Ghoshal AK: Lipoperoxidation as a vector in carbon tetrachloride hepatotoxicity. Lab Invest. 1966, 15: 132-148.

  19. 19.

    Durk H, Frank H: Carbon tetrachloride metabolism in vivo and exhalation of volatile alkanes: dependence upon oxygen parital pressure. Toxicology. 1984, 30: 249-257. 10.1016/0300-483X(84)90096-9.

  20. 20.

    Mansuy D, Fontecane M, Chottard J: A heme model study of carbon tetrachloride metabolism: mechanism of phosgene and carbon dioxide formation. Biochem Biophys Res Commun. 1980, 95: 1536-1542.

  21. 21.

    Pohl L, Schulick R, George J: Reductive oxygenation mechanism of metabolism of carbon tetrachlorideto phosgene by cytochrome P450. Mol Pharmacol. 1984, 25: 318-324.

  22. 22.

    Pohl L, Schulick R, Highet R, George J: Identification of dichloromethyl carbene as a metabolite of carbon tetrachloride. Biochem Biophys Res Commun. 1983, 117: 367-372. 10.1016/0006-291X(83)91209-3.

  23. 23.

    Tom WM, Fong D, Woo D, Prasongwatana V, Boyde TR: Microsomal lipid peroxidation and oxidative metabolism in rat liver. Chem Biol Interact. 1984, 50: 361-10.1016/0009-2797(84)90043-7.

  24. 24.

    Slater TF: Free-radical mechanisms in tissue injury. Biochem J. 1984, 222: 1-15.

  25. 25.

    Recknagel RO, Glende EA, Lowery K: Lipid peroxidation: Biochemisry, measurement and significance in liver cell injury. Toxicology of the Liver. Edited by: Plaa GL and Hewitt W. 1982, New York, Raven Press, 213-242.

  26. 26.

    ElSisi AE, Earnest DL, Sipes IG: Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species. Toxicol Appl Pharmacol. 1993, 119: 295-301. 

  27. 27.

    Hsiao G, Shen MY, Lin KH, Lan MH, Wu LY, Chou DS, Lin CH, Su CH, Sheu JR: Antioxidative and hepatoprotective effects of Antrodia camphorata extract. J Agric Food Chem. 2003, 51: 3302-3308. 

  28. 28.

    Jeong TC, Kim HJ, Park J, Ha CS, Park JD, Kim S, Roh JK: Protective effects of red ginseng saponins against carbon tetrachloride-induced hepatotoxicity in sprague dawley rats. Planta Med. 1996, 63: 136-140. 

  29. 29.

    Zimmerman SW, Norback DH, Powers K: Carbon tetrachloride nephrotoxicity in rats with reduced renal mass. Arch Pathol Lab Med. 1983, 107: 264-269.

  30. 30.

    Ogawa M, Mori T, Mori Y, Ueda S, Azemoto R, Makino Y, Wakashin Y, Ohto M, Wakashin M, Yoshida H, et al.: Study on chronic renal injuries induced by carbon tetrachloride: selective inhibition of the nephrotoxicity by irradiation. Nephron. 1992, 60: 68-73.

  31. 31.

    Fadhel ZA, Amran S: Effects of black tea extract on carbon tetrachloride-induced lipid peroxidation in liver, kidneys, and testes of rats. Phytother Res. 2002, 16 Suppl 1: S28-32. 10.1002/ptr.793.

  32. 32.

    Patil S, Kanase A, Varute AT: Effect of hepatoprotective ayurvedic drugs on lipases following CCl4 induced hepatic injury in rats. Indian J Exp Biol. 1989, 27: 955-958.

  33. 33.

    Miyake Y, Yamamoto K, Tsujihara N, Osawa T: Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids. 1998, 33: 689-695.

  34. 34.

    Jean T, Bodinier MC: Mediators involved in inflammation: effects of Daflon 500 mg on their release. Angiology. 1994, 45: 554-559.

  35. 35.

    Mandal AK, Sinha J, Mandal S, Mukhopadhyay S, Das N: Targeting of liposomal flavonoid to liver in combating hepatocellular oxidative damage. Drug Deliv. 2002, 9: 181-185. 10.1080/15227950290097615. 

  36. 36.

    IFCC methods for the measurement of catalytic concentrations of enzymes. part 3, IFCC. Method for alanine aminotransferase (l-alanine 2 -oxoglutarate aminotransferase, ec 2.6.1.2).

  37. 37.

    Pearlman FC, Lee RT: Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents. Clin Chem. 1974, 20: 447-453.

  38. 38.

    Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biocem. 1979, 95: 351-358. 10.1016/0003-2697(79)90738-3.

  39. 39.

    Jollow D, Mitchell L, Zampaglione N, Gillete J: Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacol. 1974, 11: 151-169.

  40. 40.

    Kono Y: Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978, 186: 189-195. 10.1016/0003-9861(78)90479-4.

  41. 41.

    Claiborne A: Handbook of Methods for Oxygen Radical Reaserch. Edited by: Boca Raton FL. 1985, , CRC Press, 283-284.


Home  |  主打产品  |  植物提取物  |  天然提取物  |  产品目录  |  产品解决方案  |  展会  |  联系我们  |  网站地图  |  手机版
  English     简体版     繁體版
网站首页联系我们网站地图